Semler Scientific Inc. (SMLR)
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.
The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.
The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
|IPO Date||Feb 21, 2014|
|Industry||Health Care Equipment & Supplies|
911 Bern Ct Ste 110
San Jose, California 95112-1242
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|
|Dr. Douglas Murphy-Chutorian M.D.||Chief Executive Officer, Corporate Secretary and Director|
|Andrew B. Weinstein||Senior Vice President of Finance and Accounting|
|Dr. Herbert J. Semler||Founder and Chairman Emeritus|
|Robert G. McRae||Chief Technical Officer|
|Dennis Rosenberg||Chief Marketing Officer|
Latest SEC Filings
|Jul 5, 2022||4||Statement of changes in beneficial ownership of securities|
|May 6, 2022||10-Q||Quarterly report [Sections 13 or 15(d)]|
|May 2, 2022||8-K||Current report|
|Apr 18, 2022||4||Statement of changes in beneficial ownership of securities|
|Mar 17, 2022||8-K||Current report|
|Mar 7, 2022||S-8||Securities to be offered to employees in employee benefit plans|
|Mar 4, 2022||10-K||Annual report [Section 13 and 15(d), not S-K Item 405]|
|Mar 1, 2022||4||Statement of changes in beneficial ownership of securities|
|Feb 28, 2022||8-K||Current report|
|Feb 24, 2022||4||Statement of changes in beneficial ownership of securities|